Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.

Hamid, Mohamed A; Abdelfattah, Nizar S; Salamzadeh, Jamshid; Abdelaziz, Sahar T A; Sabry, Ahmed M; Mourad, Khaled M; Shehab, Azza A; Kuppermann, Baruch D

Hamid, Mohamed A; Abdelfattah, Nizar S; Salamzadeh, Jamshid; Abdelaziz, Sahar T A; Sabry, Ahmed M; Mourad, Khaled M; Shehab, Azza A; Kuppermann, Baruch D.

Afiliación

Hamid MA; Department of Ophthalmology, Gavin Herbert Eye Institute, University of California Irvine, Irvine, CA, USA. drmohamedhamid83@mu.edu.eg.
Abdelfattah NS; Department of Ophthalmology, Minia University, Minia, 61111, Egypt. drmohamedhamid83@mu.edu.eg.
Salamzadeh J; Department of Ophthalmology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Abdelaziz STA; Department of Clinical Pharmacy, and Pharmacoeconomy and Pharma-Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sabry AM; Department of Ophthalmology, Minia University, Minia, 61111, Egypt.
Mourad KM; Department of Ophthalmology, Minia University, Minia, 61111, Egypt.
Shehab AA; Department of Ophthalmology, Minia University, Minia, 61111, Egypt.
Kuppermann BD; Department of Ophthalmology, Minia University, Minia, 61111, Egypt.

Int J Retina Vitreous ; 7(1): 26, 2021 Apr 01.

Article en En | MEDLINE | ID: mdl-33795022

Palabras clave

Aflibercept; Age-related macular degeneration (AMD); Anti-vascular endothelial growth factor (VEGF)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Retina Vitreous Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google